Press Enter to search · ESC to close

Macro

84.2% of Negotiated Drugs in China’s 2025 Medical Insurance List Saw Both Purchase Value and Volume Growth

China’s national medical insurance platform released its annual drug procurement report on November 14 in Suzhou, Jiangsu. Since the medical insurance list began dynamic adjustments in 2018, the cumulative number of negotiated drugs reached 530 by 2024. Compared with 2024 data, 84.2% of negotiated drugs achieved growth in both procurement value and volume in 2025.

Share

Related News

Cointime share card
Long-press the image to save or share
Pitch us Community Feedback